Literature DB >> 10956089

Hypotriglyceridemic effect of Anka (a fermented rice product of monascus sp.) in rats.

I K Wang1, S Y Lin-Shiau, P C Chen, J K Lin.   

Abstract

Experimental rats with hypertriglyceridemia were prepared by feeding a high-fructose diet. Dried Anka powder (2%), a rice product fermented with Monascus sp., was mixed with basic high-fructose (30%) or basal-diet feed. Serum and liver lipids were measured after 6 months. The concentrations of serum triglycerides, total cholesterol, VLDL-C, and LDL-C had significantly decreased, whereas that of HDL-C had slightly increased in 30% fructose-Anka-fed rats as compared with the 30% fructose-fed rats, but hepatic lipase activity had increased in the Anka-fed groups. The ratio of lipoprotein lipase/hepatic lipase was not significantly different between 30% fructose-Anka-fed rats and 30% fructose-fed rats. The dietary intake and weight of these two groups were approximately the same. Similar results were obtained in noninduced hypertriglyceridemic rats. The concentrations of triglycerides and cholesterol did not significantly differ in the liver. Interestingly, Anka can suppress serum triglycerides in rats with induced hypertriglyceridemia. The antioxidant enzyme SOD activity was also measured in serum, and no significant change was observed. On the basis of these findings, we suggest that Anka may be used to suppress hypertriglyceridemia and hyperlipidemia in rats and possibly in man.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10956089     DOI: 10.1021/jf9909353

Source DB:  PubMed          Journal:  J Agric Food Chem        ISSN: 0021-8561            Impact factor:   5.279


  3 in total

Review 1.  Extracts of Monascusus purpureus beyond statins--profile of efficacy and safety of the use of extracts of Monascus purpureus.

Authors:  Antonio Bianchi
Journal:  Chin J Integr Med       Date:  2005-12       Impact factor: 1.978

2.  Analyses of red fermented rice (angkak) and report of a newMonascus metabolite.

Authors:  D Wild; M Gareis; H U Humpf
Journal:  Mycotoxin Res       Date:  2002-06       Impact factor: 3.833

3.  Combined treatment with Dif1stat and diet reduce plasma lipid indicators of moderate hypercholesterolemia more effectively than diet alone: a randomized trial in parallel groups.

Authors:  Claudia Stefanutti; Fabio Mazza; Antonio Vivenzio; Serafina Di Giacomo; Giuseppina Perrone; Mariarosaria Serra; Antonello Bucci
Journal:  Lipids       Date:  2009-11-13       Impact factor: 1.880

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.